Collection
Behcet Disease
- Submission status
- Open
- Open for submission from
- 07 January 2019
- Submission deadline
- Ongoing
Since its first description in 1937, Behçet’s syndrome (BS) represents a dilemma both for clinicians and researchers. However, many steps forward the comprehension of the main pathogenetic pathways involved in the development of BS have been done. In addition, the management of this complex neutrophilic vasculitis has been improved, and now an increasing number of different drugs are available for its treatment. Given the broad spectrum of manifestations, the interest for BS involves many different specialists (dermatologist, ophthalmologist, neurologist, and rheumatologist). In addition, internists must be aware of this condition, and take BS into account for the differential diagnosis of specific clinical settings. This collection is focussed on the pathogenetic mechanisms, the main clinical phenotypes and specific treatments have been dedicated to Behcet's syndrome.
Editors
-
Giacomo Emmi
Prof. Giacomo Emmi is a clinical immunologist, associate Professor of Internal Medicine at the University Hospital Careggi. He is also responsible for the clinical sub-network Autoimmune Diseases of the Tuscan Network of Rare Diseases and deputy director of the School of Specialization in Internal Medicine at the University of Florence (Italy)
Articles (18 in this collection)
-
-
Musculoskeletal manifestations in children with Behçet’s syndrome: data from the AIDA Network Behçet’s Syndrome Registry
Authors (first, second and last of 57)
- Carla Gaggiano
- Anna Maselli
- the AIDA Network
- Content type: IM - ORIGINAL
- Open Access
- Published: 07 March 2023
- Pages: 743 - 754
-
The diagnostic role of pathergy test in patients with Behçet’s disease from the Western Europe
Authors (first, second and last of 15)
- Antonio Vitale
- Virginia Berlengiero
- Luca Cantarini
- Content type: IM - ORIGINAL
- Published: 21 December 2022
- Pages: 77 - 83
-
Development and implementation of the AIDA International Registry for patients with Behçet’s disease
Authors (first, second and last of 92)
- Antonio Vitale
- Francesca Della Casa
- Autoinflammatory Diseases Alliance (AIDA) Network
- Content type: IM - ORIGINAL
- Open Access
- Published: 14 July 2022
- Pages: 1977 - 1986
-
Clinical profile and evolution of patients with juvenile-onset Behçet’s syndrome over a 25-year period: insights from the AIDA network
Authors (first, second and last of 20)
- Jurgen Sota
- Donato Rigante
- Luca Cantarini
- Content type: IM - ORIGINAL
- Open Access
- Published: 09 April 2021
- Pages: 2163 - 2171
-
Characteristics and outcomes of Behçet’s syndrome patients with Coronavirus Disease 2019: a case series of 10 patients
Authors (first, second and last of 7)
- Berna Yurttaş
- Mert Oztas
- Emire Seyahi
- Content type: CE-Research Letter to the Editor
- Published: 09 July 2020
- Pages: 1567 - 1571
-
HLA-B*51 allelic and carrier frequency in Kazakhstan: insights into Behçet’s disease prevalence in Central Asia
Authors (first, second and last of 6)
- Dimitri Poddighe
- Aida Turganbekova
- Saniya Abdrakhmanova
- Content type: IM - ORIGINAL
- Published: 30 May 2020
- Pages: 325 - 331
-
Behçet’s syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics
Authors (first, second and last of 13)
- Jurgen Sota
- Donato Rigante
- Luca Cantarini
- Content type: IM - ORIGINAL
- Published: 01 February 2020
- Pages: 1031 - 1039
-
Behçet’s syndrome: focus on pathogenetic background, clinical phenotypes and specific treatments
Authors
- Giacomo Emmi
- Domenico Prisco
- Content type: Editor’s Page
- Published: 17 July 2019
- Pages: 639 - 643
-
Distribution of rs17482078 and rs27044 ERAP1 polymorphisms in a group of Italian Behçet’s syndrome patients: a preliminary case–control study
Authors (first, second and last of 10)
- Maria Carmela Padula
- Pietro Leccese
- Salvatore D’Angelo
- Content type: IM - ORIGINAL
- Published: 28 February 2019
- Pages: 713 - 718
-
Phenotypes in Behçet’s syndrome
Authors
- Emire Seyahi
- Content type: IM - REVIEW
- Published: 11 February 2019
- Pages: 677 - 689
-
Pathergy testing: prospective comparison of dermatoscopic evaluation and naked eye examination
Authors (first, second and last of 4)
- Aysegul Sevim Kecici
- Zekayi Kutlubay
- Yalcin Tuzun
- Content type: IM - ORIGINAL
- Published: 08 February 2019
- Pages: 699 - 703
-
Assessment of deep venous thrombosis in the lower extremity in Behçet’s syndrome: MR venography versus Doppler ultrasonography
Authors (first, second and last of 5)
- Burcin Tutar
- Fatih Kantarci
- Emire Seyahi
- Content type: IM - ORIGINAL
- Published: 02 February 2019
- Pages: 705 - 711
-
Update on the treatment of Behçet’s syndrome
Authors
- Sinem Nihal Esatoglu
- Gulen Hatemi
- Content type: IM - REVIEW
- Published: 25 January 2019
- Pages: 661 - 675
-
Triggering agents and microbiome as environmental factors on Behçet’s syndrome
Authors
- Gonca Mumcu
- Haner Direskeneli
- Content type: IM - REVIEW
- Published: 06 December 2018
- Pages: 653 - 660
-
Does illness perception associate with disease symptoms in Behçet’s disease?
Authors (first, second and last of 6)
- Gonca Mumcu
- Fedayi Yağar
- Tulin Ergun
- Content type: IM - ORIGINAL
- Published: 30 November 2018
- Pages: 691 - 697
-
Vascular Behçet’s syndrome: an update
Authors (first, second and last of 7)
- Giacomo Emmi
- Alessandra Bettiol
- Domenico Prisco
- Content type: IM - REVIEW
- Published: 29 November 2018
- Pages: 645 - 652
-
Long-term effectiveness and safety of switching from originator to biosimilar infliximab in patients with Behçet’s disease
Authors (first, second and last of 6)
- Giuseppe Lopalco
- Vincenzo Venerito
- Florenzo Iannone
- Content type: Research Letter to the Editor
- Published: 25 October 2018
- Pages: 719 - 722